chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; 99 deg. Fahrenheit fever; Achey; Tiredness; Sore arm at injection site; This is a spontaneous report from a contactable consumer (patient). A 23-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 18Feb2021 (at the age of 23-year-old) as a dose 2, single for COVID-19 immunization. The patient's medical history included Factor V Leiden. The patient had no known allergies. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247), via an unspecified route of administration in arm left on 28Jan2021 (at the age of 23-year-old) as a dose 1, single for COVID-19 immunization. It was reported that, the patient was not pregnant at time of vaccination. Other vaccine in four weeks was reported as no. No covid prior vaccination and no covid tested post vaccination. On 19Feb2021, the patient experienced headache, achey, tiredness, 99 deg. Fahrenheit fever, sore arm at injection site. Treatment was not received for the events. On 19Feb2021, the patient underwent lab tests and procedures which included fever (body temperature), resulted as 99 Fahrenheit. The outcome of the events was recovered on an unspecified date in 2021.  Follow-up attempts completed. No further information expected.
Patient was given covid vaccine in left arm too low. Patient did develop a systemic reaction to the covid vaccine (which is now resolved) and has a rash on arm.
Approximately 4 minutes after receiving my vaccine I felt warmth down injected arm. Approximately 20 minutes post injection, I experienced a drop in my blood pressure, heaviness in my legs (like walking through cement), and ringing in my ears. At approximately 12:30-12:45pm I experienced mental fog (I couldn't remember how to turn off my windshield wipers), increased heart rate, rapid onset of feelings of panic, minor shortness of breath, neck/clavicle tightness on side of injection, and sweating. Between approximately 1:30pm and 2:30pm I continued to have extreme sweating, as well as: increased pulse, fatigue, dry throat, muscle weakness/shakiness, brain fog, and headache. At approximately 3:30 I hit my knee on the bed frame and felt like the wind had been knocked out of me and immediately had a severe drop in blood pressure that felt similar to a vasovagal event. I called the vaccine clinic and my symptoms were noted and I was told to seek help if my symptoms worsened or I felt like I was going to pass out. My symptoms have not worsened but I am still experiencing extreme sweating along with shivering, shakiness, blood pressure changes with movement (orthostatic hypotension), and fatigue - time is currently 5:50pm
My daughter received the Flu Mist vaccine on Saturday.  On Sunday, she woke up dizzy and with a fever of 100.2.  Reported being achy, sore throat.  Fever climbed on Monday to 101.  By Tuesday, tempature was back to normal
1/6/10 H1N1 given 1/8/10 c/o nausea, light head, vomited x 1; soreness. 1/9/10 c/o cough. 1/11 improved. A number of staff have cough at present.
Patient received his COVID-19 Booster, walks from the vaccine table to the observation area. Patient spoke with the observation nurse regarding his vaccine card. Momentarily patient verbalizes he is feeling funny, and he bends over hand on his knees, and patient falls backward on to the floor, with his lower back taking most of the impact and rolling back his head on the floor. Patient was unresponsive for 15-20 seconds. Emergency called. Patient regains responsiveness after stimulating the patient. The patient immediately stands up asking where he was and the patient did not have recollection of what happened. Patient was calmed down and sat down. Legs elevated on the chair. Patient was Pale, cyanotic, anxious. Vital Signs were 97.0 F via Oral, Pulse 68, BP 104/63, 5 minutes after 96/56 Oxygen saturation 86% on room air. EMS arrived 12:34 and patient was picked up by ambulance 12:53.
12 hrs after vaccine, blotchy red, non-raised rash formed dependent to injection site below deltoid muscle. Lasted 2 days. Painful but not itchy.
6 hours after the injection, i developed lymph node swelling on my collar bone approx. 3 in x 3in area, headache, watery ices and sneezing that lasted 48hours.  As of today, April 24th the swollen lymph node is still present
Unable to create wheel on first try, administered a second time on Left forearm and wheel was successfully created
Rash began around both armpits then traveled down inside of both arms then to front torso..saw dermatology twice. Having a biopsy in 2 spots second time. Result was overactive capillaries  expected to have been caused by active immune system. Currently, over 4 months later,  some of the early rash has started to fade while new ones emerge. Rash does not hurt nor itch.  New rash spots are on legs. Have not been prescribed any medication other than additional Vitamin C.
Large welt/hive, completely round; Itching; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 31Jul2023 as dose 6 (booster), single (Lot number: GM1767) at the age of 61 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergy to Iodine" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction: "known allergy". Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Batch/Lot number: unknown), for COVID-19 Immunization; Bnt162b2 (DOSE 2, SINGLE, Batch/Lot number: unknown), for COVID-19 Immunization; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE, Batch/Lot number: unknown), for COVID-19 Immunization; Bnt162b2 (DOSE 4 (BOOSTER), SINGLE, Batch/Lot number: unknown), for COVID-19 Immunization; Bnt162b2 (DOSE 5 (BOOSTER), SINGLE, Batch/Lot number: unknown), for COVID-19 Immunization. The following information was reported: PRURITUS (non-serious) with onset 31Jul2023, outcome "recovering", described as "Itching"; URTICARIA (non-serious) with onset 31Jul2023, outcome "recovering", described as "Large welt/hive, completely round". Therapeutic measures were not taken as a result of urticaria, pruritus. Additional information: Welt was still present after 48 hours. The vaccination facility type was a pharmacy or drug store. The patient had no other vaccine in four weeks. The patient had no covid prior vaccination and was not tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
pt recvd vax;exp shaking chills; violent retching, fever 105; sudden onset 2 hrs after vax; no other evidence of illness;
Patient had the flu shot with no reaction, then the next day she received the Pneumovax and a day later she had redness and swelling.
Patient presented to the ED and was subsequently hospitalized for alcohol-induced pancreatitis within 6 weeks of receiving covid vaccination.
blood pressure shot up to 163 over 73, internal organs were trembling, feeling about to faint
This spontaneous report as received from a physician via a field employee refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL. On an unknown date within a few dates after receiving GARDASIL the patient experienced cervical lymphadenopathy. The cervical lymphadenopathy occurred on the same side as injection site for GARDASIL. The patient had chest X-ray and unspecified blood work. The outcome of cervical lymphadenopathy was reported as resolved in 2 week (reported as dissipated in 2 weeks). This case is linked to 1402USA004625 (same reporter link). Additional information has been requested.
Headache began the next morning and had been returning daily with pain and pressure behind the eyes.  Some sinus inflammation but clear discharge.  Swollen lymph node on left side of neck started 1/10 with minor pain.
103 fever, involuntary arm movements when stretching, nausea, rapid heart rate 168 for at least 2 hours
Lethargy, Brain fog, night sweats, huge increase in Arthritis pain all for three days, still lingering
Losing her hair; This is a spontaneous report from a contactable consumer or other non healthcare professional (reporter's friend). A 85-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: not reported), via an unspecified route of administration as (at age of 85-years-old) dose number unknown, single for covid-19 immunisation. Medical history included diabetic, high blood pressure (Takes high blood pressure medication (name not specified). Past drug included statins (name not specified). On an unspecified date, the patient experienced losing her hair. The reporter has heard that she needs to wait 2 weeks after her second Pfizer vaccine to travel. She wanted to find out if that is correct information and stated that she had her second vaccine on 15Apr2021 and had no issues at all. She states her friend, reports losing her hair after receiving the Pfizer Covid vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Started with strange feeling not sore throat, discomfort in throat and then cough which was tight, then congestion, chills, pink eye on left eye, no temperature. Went to see doctor on 15Sep2021 for being sick for 5 days before. Congestion is finally starting to subside now.
Injection site reactions in her left arm.  The area was red; Injection site reactions in her left arm / Hot to touch; Arm was sore; 1st dose 1/15/2020 and has not received the 2nd dose; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included rheumatoid arthritis.   On 15th January 2020, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced injection site erythema, injection site warmth, pain in arm and incomplete course of vaccination. On an unknown date, the outcome of the injection site erythema, injection site warmth and pain in arm were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the injection site erythema, injection site warmth and pain in arm to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix and experienced injection site reactions in her left arm.   The area was red, hot to touch and the arm was sore for several days. Till the tme of reporting, the patient did not receive 2nd dose, which led incomplete course of vaccination. This case has been linked with case US2020244407, reported by same reporter. The reporter did not consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020244407:same reporter
Patient received vaccination on 3/23 and began to have hives during the early morning of 3/26. Patient insists that they there are no other factors that could have contributed to this reaction. Patient was advised to take BENADRYL and go to her PCP where she was prescribed prednisone.
Painful chills and muscle cramps. High-grade fever (101.5 degrees). Muscle aches. Fatigue and headache. All symptom appeared 11 hours after taking the first dose of the vaccine and are currently present.
This spontaneous report was been received from a health care worker referring to an 18 year old female patient. No medical history was reported. Approximately on 23-DEC-2015, the patient was vaccinated with a dose of improperly stored GARDASIL 9, dose, route and frequency: unknown, lot number: L016429, expiry date: 09-AUG-2017). No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Severe injection site soreness & local swelling; swollen neck on left side; headache; nausea; vomiting; severe body pain, myalgia.
Facial pain or headache becomes more severe, drowsiness or confusion , swelling of the forehead or eyelids, vision problems including blurred and double vision, seizure, dry mounth nausea tiredness constipation, double vision Diplopia, one aye is affected, vertigo, speech or walking
Pregnancy dated by LMP consistent with 7 week ultrasound. Received first dose before pregnancy was known, received second dose at 7 weeks gestation. Started prenatal care, and had normal labs, euthyroid state, negative/normal fetal cell free DNA (non-invasive prenatal testing) done at 11 weeks with normal fetal nuchal translucency and nasal bone present. Missed spontaneous abortion discovered at 12 weeks 6 days (no fetal heart beat), D&C done, awaiting cytogenetics now.
Evaluation of right arm redness and swelling. Old records were reviewed. She does not speak or understand the language, and interpreter was not available at such short notice. Nursing staff reports that patient's right upper arm is red and swollen. She received her pneumonia vaccine yesterday, 8/3/11, in the right arm. Cool compresses have been applied, but nursing staff requested evaluation. Patient did not want to remove her sweater, and appeared chilled. Further history is unobtainable. Extremities: RUE, mid-distal arm (+)diffuse erythema with mild swelling from mid arm to elbow, (+)mild tenderness to palpation; injection site of recent vaccine was superior to the diffuse redness with only mild surrounding erythema at the site; RUE ROM intact and full; radial pulses palpable and equal; grip strength symmetrical; LE without erythema or edema Cellulitis - right upper extremity - possible vaccine reaction, but questionable given location of physical findings
Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for carcinoma of floor of mouth, COPD, malignant neoplasm of colon, ocular HTN, hyperlipidemia, hx of cerebrovascular accident, abnormal imaging of lung, nicotine dependence. Pt has a Smoking pack year of 100. Pt was scheduled for a g tube placement on 5/13 due to malnutrition and weight loss. Deceased on 5/10 under hospice care with no cause of death listed.
Patient's mom stated on vaccination questionnaire on question asking if "patient has ever had reaction, fainted, or felt dizzy after receiving a vaccine or has any physician or other healthcare professional ever cautioned or warned you about receiving certain vaccines or receiving vaccines outside of a medical setting?"  yes - that pt has a fear of needles and mom also stated that she had passed out before, after receiving a vaccine at another pharmacy location in the past.  I spoke with Mom about giving her an ice pack to hold on her neck from the get go and then I spoke with patient as well.  Her eyes started to flutter and I could tell she was near passing out, so I had her lean over with arms on knees and head down, while I held ice pack on her neck until she felt well enough to sit up (probably for about 3-4 minutes).  She then sat up and probably sat in our immunization area for an additional 10 minutes or so and at that point, left with her Mom and 2 other siblings.
This spontaneous report was received from a medical assistant and refers to a 16-year-old male patient. His concurrent conditions, past medical history, concomitant medications or drug reactions and allergies were not reported. On 25-JAN-2019, the patient was inadvertently vaccinated with an adult dose of VAQTA (exact dose, route and site of administration were not reported) lot # R018775, expiry date 09-AUG-2019 for prophylaxis. No adverse effects were reported. The outcome of the incorrect dose administered was unknown.
This spontaneous report as received from a medical assistant (also reported as administrator) refers to a patient of unknown age and gender. On 06-JUN-2016, unspecified dose of improperly stored PROQUAD (lot # L050907, expiry date: 14-JUN-2017/M004895, expiry date: 26-JUN-2017) was administrated to the patient. No adverse events were reported. The outcome was unknown. No product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Patient passed out in observation area, another patient called out for assistance. Patient appeared diaphoretic, bp 85/50. I have patient water and observed him for an additional 15 mins afterward. Retook blood pressure, 110/78. patient awake, talking to father. States he "feels much better".
The wrong client was inadvertently given the influenza vaccine. This client had already received an annual flu vaccine for this flu season, so client ended up receiving two influenza vaccines within 6 days of each other.
Shoulder pain; Neck pain; Extreme tiredness; Extreme body ache; Muscle pain; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Apr2021 at 18:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included ibuprofen (ADVIL), ascorbic acid, calcium carbonate, calcium pantothenate, calcium phosphate, chromium, cyanocobalamin, folic acid, magnesium carbonate, magnesium hydroxide, manganese gluconate, nicotinic acid, potassium bicarbonate, potassium carbonate, potassium phosphate dibasic, pyridoxine hydrochloride, quercetin, riboflavin sodium phosphate, sodium bicarbonate, sodium phosphate, thiamine hydrochloride, thioctic acid, zinc ascorbate (EMERGEN C), zinc (MANUFACTURER UNKNOWN), all taken from unknown dates for unspecified indications and birth control pills (MANUFACTURER UNKNOWN). The patient previously took pork and its derivatives and bees. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 18:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021, within 15 minutes of vaccine, the patient experienced severe neck and shoulder pain on injection side and on the same day, the patient experienced extreme tiredness, extreme body ache, muscle pain and nausea. The clinical outcome of the events severe neck and shoulder pain on injection side, extreme tiredness, extreme body ache, muscle pain and nausea were resolved on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Saturday 4/17/21 began to feel tired achy had severe muscle and joint pain like when I had COVID, chills/sweating, right armpit is swollen. Slept the entire day, nauseous.
Had 101 deg F fever all of 17 Sept 2022.  Fever gone 18 Sept 2022. On 27 Sept 2022, began having itchy rash on the inside of the arm at the left elbow and the right abdomen just below the ribs.  Rash matches pictures of shingles. By 05 Oct 2022, rash had grown and coalesced into itchy red patches with pus and crust and spread to other areas of abdomen and right arm.  Plan to see doctor about apparent shingles.
3 days after the vaccine:  Spastic Diarrhea (2 episodes).  Shortness of breath.  Loss of balance. Loss of appetite.  Very low energy.  Foggy brain, constant ringing in the ears: constant "pressure cooker". Yesterday, visited my generalist's who said they have had several cases with similar symptoms.
Employee received Tdap the afternoon of 12/8/2008 by 19:00 that evening he reports that the injection site was painful , swollen and hard.  He did nothing until the next day when he reported to Employee health.  He was given 2 ibruprofen and  ice to applt to  the site. He was afebrile and vitals signs stable.
01/04/23 presents to ED for "shortness of breath". PMHx of "prostate cancer, UTI, GERD, Interstitial lung disease, COPD"
This is a spontaneous report from a contactable nurse received via a Pfizer sales representative. This nurse reported similar events for two patients. This is the first of two reports. A 16-year-old patient of an unspecified gender received TRUMENBA and meningococcal vaccine a/c/y/w (MCV4), both via unspecified route of administration on unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient was given meningococcal group b rlp2086 and MCV4 on the same visit at different locations. The patient ended up having severe headaches and vomiting and needed to be hospitalized and ended up getting a spinal tap on an unspecified date. It was reported that the events took place after the use of the products. The outcome of the events was unknown. The information on the batch/lot number and expiration date has been requested.; Sender's Comments: Based on the information available, the Company cannot exclude that the suspect drug trumenba contributed to the development of the reported events headaches and vomiting .,Linked Report(s) : US-PFIZER INC-2018350877 Same reporter/drug/event, different patient.
DIZZINESS; NAUESA; HEADACHE CONSTANT FOR NOW ONE WEEK AND A DAY; WITH SEVERE SENSITIVITY TO SUNLIGHT
19MAR92 screaming, T spiked to 105, refused fluids; 20MAR92 temp still spiking, vomiting, flushed, diarrhea;
03/05/2021 @ 1100: Medic at site called & stated patient w/c/o difficulty swallowing; VS: BP-160/80; HR: 110; 02 sat on RA:96%; This nurse went to check on patient,  patient crying and trying to be calm. Patient stated she had anaphylaxis before with abx but did not have an Epi pen. EMS called and we were instructed to go ahead and give patient Epi eventhough she was sating @ 96%. Instructions followed, Epi 0.3 mg auto injected to patients right lateral thigh by EMT. VS before EMS arrival: BP: 156/104; HR: 106; O2 on RA: 97%. Care turned over to EMS. This nurse contacted patient on 03/05/2021 @  2115 - p/patient, she was given an Epi neb and another dose of Epi in ED. Patient left ED on oral steroids - dcd @ 1600.
Nov 5. Patient collapsed at school. Felt extreme vertigo with pulling to left. Felt faint, called for help. Taken to nurse's office. EMT called. Transported to hospital. Severe vomiting, nystagmus with vertigo. Disorientation. VS. stable. Admitted on 11/5/09. CT scan, MRI, labs. 11/10/09 Medical records received for dates 11/5/09. DX: Acute vestibular neuronitis, labyrithitis. Presents with c/o profound dizziness, episode was spinning vertigo, dizziness, multiple episodes of vomiting and could not get up off the floor, no HA. Pt had H1N1 vax x1 day ago, difficulty voiding, unable to ambulate. 11/16/09 DC instructions from date 11/5/09 received. No additional info.